HSPA5 and malignant glioma: Since secretory Par-4 functions by binding to membrane GRP78, which is overexpressed in most cancer cells but not normal cells, secretory Par-4 is an attractive candidate for potentially overcoming therapy-resistance not only in malignant gliomas but in broad spectrum of cancers.